Our findings analyzed herein suggest that the administration of EYETAS has a neuroprotective effect in rAION, as evidenced by both RGC morphometry and visual functional preservation. Treatment with EYETAS preserved the survival of RGCs by reducing the apoptotic RGCs post infarct. In addition, EYETAS supplementation preserved the visual function, as evidenced by FVEP.
Supportive Research
Serum levels of eicosapentaenoic acid are associated with a significantly lower risk of choroidal neovascular AMD in a study of 290 patients with wet AMD and 144 controls without AMD. The red blood cell membrane levels of eicosapentaenoic and docosahexanoic fatty acids, which represent long-term levels of PUFAs, are associated strongly with a lower risk for choroidal neovascular AMD.
Merle, et al. 2014
In a recent cross-sectional case-controlled study, neovascular AMD was associated with lower circulatory levels of Omega 3 and higher levels of Omega-6 fatty acids.
LK Ng, et al. 2019
Omega-3 reduce choroidal neovascular AMD in a mouse model. The levels of VEGF and leukocytes infiltration were also reduced in the retina and choroid in the Omega 3 fed mouse model.
Yanai, et al. 2014